Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanna Robson

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Best Practice & Research. Clinical Rheumatology|December 12, 2018
Introduction, epidemiology and classification of vasculitisRichard A Watts, Joanna Robson
Rheumatic Diseases Clinics of North America|August 7, 2010
Outcome measures in ANCA-associated vasculitisRavi Suppiah, Joanna Robson, Raashid Luqmani
Current Rheumatology Reports|January 29, 2021
Patient Reported Outcomes in Large Vessel VasculitidesJoanna Robson, Sarah Mackie, Catherine Hill
Medical Teacher|August 27, 2014
Patient experiences of participation in a medical student teaching workshopLaura Watts, Tess Mcpherson, Joanna Robson, et al.
BMJ Case Reports|January 12, 2026
Treatment of dual-positive anti-glomerular basement membrane and ANCA disease using rituximab in addition to plasma exchange, corticosteroids and cyclophosphamideAmy Chew, Nichita Gavrilescu, Alan Pham, et al.
Clinical and Experimental Rheumatology|September 10, 2019
Early development of new cardiovascular risk factors in the systemic vasculitidesSara Monti, Joanna Robson, Catherine Klersy, et al.
Annals of the Rheumatic Diseases|May 20, 2020
Mixed methods study of clinicians' perspectives on barriers to implementation of treat to target in psoriatic arthritisEmma Dures, Julie Taylor, Sasha Shepperd, et al.
Rheumatology (Oxford, England)|December 13, 2016
The association of vascular risk factors with visual loss in giant cell arteritisMax Yates, Alex J MacGregor, Joanna Robson, et al.
Rheumatology (Oxford, England)|September 11, 2014
Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trialsJoanna Robson, Helen Doll, Ravi Suppiah, et al.
Annals of the Rheumatic Diseases|November 19, 2013
Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trialsJoanna Robson, Helen Doll, Ravi Suppiah, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Best Practice & Research. Clinical Rheumatology|December 12, 2018
Introduction, epidemiology and classification of vasculitisRichard A Watts, Joanna Robson
Rheumatic Diseases Clinics of North America|August 7, 2010
Outcome measures in ANCA-associated vasculitisRavi Suppiah, Joanna Robson, Raashid Luqmani
Current Rheumatology Reports|January 29, 2021
Patient Reported Outcomes in Large Vessel VasculitidesJoanna Robson, Sarah Mackie, Catherine Hill
Medical Teacher|August 27, 2014
Patient experiences of participation in a medical student teaching workshopLaura Watts, Tess Mcpherson, Joanna Robson, et al.
BMJ Case Reports|January 12, 2026
Treatment of dual-positive anti-glomerular basement membrane and ANCA disease using rituximab in addition to plasma exchange, corticosteroids and cyclophosphamideAmy Chew, Nichita Gavrilescu, Alan Pham, et al.
Clinical and Experimental Rheumatology|September 10, 2019
Early development of new cardiovascular risk factors in the systemic vasculitidesSara Monti, Joanna Robson, Catherine Klersy, et al.
Annals of the Rheumatic Diseases|May 20, 2020
Mixed methods study of clinicians' perspectives on barriers to implementation of treat to target in psoriatic arthritisEmma Dures, Julie Taylor, Sasha Shepperd, et al.
Rheumatology (Oxford, England)|December 13, 2016
The association of vascular risk factors with visual loss in giant cell arteritisMax Yates, Alex J MacGregor, Joanna Robson, et al.
Rheumatology (Oxford, England)|September 11, 2014
Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trialsJoanna Robson, Helen Doll, Ravi Suppiah, et al.
Annals of the Rheumatic Diseases|November 19, 2013
Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trialsJoanna Robson, Helen Doll, Ravi Suppiah, et al.
Pageof 3